Rchr
J-GLOBAL ID:201801010236331176   Update date: Apr. 14, 2024

Shun-ichi Watanabe

ワタナベ シュンイチ | Shun-ichi Watanabe
Affiliation and department:
Research field  (1): Respiratory surgery
Research theme for competitive and other funds  (3):
  • 2021 - 2024 Development study on pathological predictive biomarkers for cancer treatment
  • 2000 - 2001 The therapeutic effect of anti-VEGF neutralizing antibody against carcinomatosa pleuritis
  • 1999 - 1999 endotoxin shockにおける細胞接着分子の役割およびその治療法の解明
Papers (234):
  • Haruto Sugawara, Nao Kikkawa, Kimiteru Ito, Hirokazu Watanabe, Sawako Kaku, Hiroyuki Akai, Osamu Abe, Shun-Ichi Watanabe, Yasushi Yatabe, Masahiko Kusumoto. Is 18F-fluorodeoxyglucose PET recommended for small lung nodules? CT findings of 18F-fluorodeoxyglucose non-avid lung cancer. The British journal of radiology. 2024. 97. 1154. 462-468
  • Akifumi Mochizuki, Kouya Shiraishi, Takayuki Honda, Ryoko Inaba Higashiyama, Kuniko Sunami, Maiko Matsuda, Yoko Shimada, Yasunari Miyazaki, Yukihiro Yoshida, Shun-ichi Watanabe, et al. Passive smoking-induced mutagenesis as a promoter of lung carcinogenesis. Journal of Thoracic Oncology. 2024
  • Takaki Akamine, Kazuo Nakagawa, Kimiteru Ito, Hirokazu Watanabe, Masaya Yotsukura, Yukihiro Yoshida, Yasushi Yatabe, Masahiko Kusumoto, Shun-Ichi Watanabe. ASO Visual Abstract: Impact of 18F-FDG PET on TNM Staging and Prognosis in Thymic Epithelial Tumors. Annals of surgical oncology. 2024. 31. 2. 1146-1147
  • Aritoshi Hattori, Kenji Suzuki, Kazuya Takamochi, Masashi Wakabayashi, Yuta Sekino, Yasuhiro Tsutani, Ryu Nakajima, Keiju Aokage, Hisashi Saji, Masahiro Tsuboi, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer with radiologically pure-solid appearance in Japan (JCOG0802/WJOG4607L): a post-hoc supplemental analysis of a multicentre, open-label, phase 3 trial. The Lancet. Respiratory medicine. 2024
  • Takaki Akamine, Kazuo Nakagawa, Kimiteru Ito, Hirokazu Watanabe, Masaya Yotsukura, Yukihiro Yoshida, Yasushi Yatabe, Masahiko Kusumoto, Shun-Ichi Watanabe. Impact of 18F-FDG PET on TNM Staging and Prognosis in Thymic Epithelial Tumors. Annals of surgical oncology. 2024. 31. 1. 192-200
more...
MISC (75):
  • 赤嶺 貴紀, 中川 加寿夫, 四倉 正也, 吉田 幸弘, 渡辺 裕一, 楠本 昌彦, 渡辺 俊一. 胸腺上皮性腫瘍に対する術前FDG-PET検査の有用性について. 肺癌. 2022. 62. 6. 616-616
  • 竹村 千尋, 四倉 正也, 加島 淳平, 吉田 幸弘, 渡辺 裕一, 中川 加寿夫, 谷田部 恭, 楠本 昌彦, 渡辺 俊一. CT上すりガラス成分を伴う肺多形癌切除例の臨床学的特徴の検討. 肺癌. 2022. 62. 6. 680-680
  • 藤川 遼, 村岡 祐二, 加島 淳平, 四倉 正也, 吉田 幸弘, 中川 加寿夫, 伊藤 公輝, 渡辺 裕一, 楠本 昌彦, 渡辺 俊一, et al. 浸潤性肺腺癌の新Grade分類と画像・臨床病理・分子生物学的特徴. 日本呼吸器外科学会雑誌. 2022. 36. Suppl. O20-4
  • 藤原 和歌子, 川崎 成章, 藤川 遼, 四倉 正也, 吉田 幸弘, 中川 加寿夫, 吉田 朗彦, 堀之内 秀仁, 谷田部 恭, 大江 裕一郎, et al. ROS1陽性非小細胞肺癌に対しCrizotinib治療後にサルベージ手術を施行した1例. 日本胸部外科学会関東甲信越地方会要旨集. 2021. 187回. 24-24
  • 藤原 和歌子, 川崎 成章, 藤川 遼, 四倉 正也, 吉田 幸弘, 中川 加寿夫, 吉田 朗彦, 堀之内 秀仁, 谷田部 恭, 大江 裕一郎, et al. ROS1陽性非小細胞肺癌に対しCrizotinib治療後にサルベージ手術を施行した1例. 日本胸部外科学会関東甲信越地方会要旨集. 2021. 187回. 24-24
more...
Lectures and oral presentations  (1):
  • Sleeve resection for centrally located tumors
    (25th ESTS (European Society of Thoracic Surgeons) MEETING 2017)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page